As CEO, Will owns and drives the strategy that defines and delivers the Tetratherix mission, vision and culture. Including the successful acquisition of a company he founded in 2013, Will’s prior global success in the commercialisation of life-changing biomed innovations has helped us become a contemporary biomedical platform with big ambitions.

Dr. Ali Fathi is our founder and CTO, and is a world renowned, talented engineer who sits at the intersection of biology, chemistry and medicine. His unique approach to engineering science-based solutions for the real world has been pivotal in shaping the company’s technical strategies and vision for the future.

Cherie is the epitome of a strategic CFO. Cherie has a long history of strategic financial stewardship in our industry. Cherie has an unparalleled combination of leading global financial processes with fast-growing innovative thinking - a combination that allows us to grow rapidly while ensuring commercial stability & reliability.

Tez co-founded the company and serves as COO, overseeing our operations and advanced manufacturing initiatives. Tez is an extremely experienced chemical engineer who has over a decade of experience in bespoke compounding, polymer production & infrastructure design for complex biomaterials - a skillset that stands alone in our industry.

As a world-class researcher with decades of experience in translational research, Simin manages and drives our chemistry and analytics program. Combining both a calm temperament and a meticulous nature, Simin is a foundational member of the team and is our North Star in chemistry development.

Ruth has unparalleled experience in the quality and regulatory functions of the global medical device industry, which are critical in her role to obtain registration and market clearance for our Tetramatrix derivatives. Ruth has a unique ability to be both dynamic and meticulous in how she applies her skill set – a rarity in the industry.

Bahar is our Production Lead who is the glue between our quality systems, polymer production and customer supply. Bahar’s cross functional capabilities, diligence and combination of problem solving with a growth mindset mean we efficiently get our products to customers and the patients who need them.

Farshad is a Chemical and Biomolecular Engineering researcher with a distinguishable scientific track record in material innovation and biomedical technologies. Farshad embodies the TTX values and leads our research programs and creatively marries our foundational science with global healthcare needs.

Cassie is a central pillar in our commercial engine. Managing our financial operations, she has a unique ability to keep the financial wheels turning and managing our cashflow velocity in line with our commercial development. Cassie’s extreme ownership has helped cornerstone our monetary culture.

With a diverse and valuable set of experiences in the sector as a Financial Controller, Alex is the perfect conduit between financial performance and sustainability which helps us clearly articulate our corporate strategy to financial markets and our commercial stakeholders around the world.

As our Quality Engineer Tara brings her experience from some of the biggest players in our industry to our development and production systems. Tara’s standout approach to teamwork and systems synergy has helped lay a framework for rapid growth across the platform.

Emma serves as our Chair of the board and has experience of senior executive & director roles for significant players in our industry over multiple decades. Emma has operational expertise in finance, operations and distribution of medical technologies which makes her a thought leader in our market.

As CEO, Will owns and drives the strategy that defines and delivers the Tetratherix mission, vision and culture. Including the successful acquisition of a company he founded in 2013, Will’s prior global success in the commercialisation of life-changing biomed innovations has helped us become a contemporary biomedical platform with big ambitions.

Dr. Ali Fathi is our founder and CTO, and is a world renowned, talented engineer who sits at the intersection of biology, chemistry and medicine. His unique approach to engineering science-based solutions for the real world has been pivotal in shaping the company’s technical strategies and vision for the future.

Driven by high conviction alignment, Lants is a deep tech investor solving global problems in science. Finessed over decades, Lants has a unique way of aligning strategy, people and mission at a board level as well as in operations. Lants also sits as the Chair of our Nomination & Remuneration Committee.

David has over 25 years experience in equity capital markets, corporate finance, M&A and venture capital. David has been an active investor in the biomedical and medtech arena for decades and is well renowned for his work in driving investment returns for shareholders - something he helps drive in our board.

John is our independent non-executive director and bringing extensive experience in the medical device industry, from ideation to manufacturing and regulatory approval. He led Atomo’s rapid test platform to IPO, managed product development at Unilife and ResMed, and holds degrees in Mechanical Engineering, Systems Engineering, and an MBA.

Gillian has over 25 years of audit and financial reporting experience, and was a Registered Company Auditor. As a previous audit partner at BDO helping numerous ASX listed clients, Gillian also serves as the Chair of our Audit & Risk Committee where her pragmatism marries perfectly with process.

Maurizio is an undisputed global leader in our industry. Maurizio’s career spans over 30 years at the forefront of biomedical innovation, global and public health, focusing on innovation to improve lives around the world. Maurizio has pioneered new models for innovation and investment with companies and governments around the world.